Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_Supreme_Court_case
|
| gptkbp:area |
gptkb:US_patent
declaratory judgment |
| gptkbp:citation |
549 U.S. 118 (2007)
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:date |
January 9, 2007
|
| gptkbp:decidedBy |
gptkb:Supreme_Court_of_the_United_States
|
| gptkbp:docketNumber |
05-608
|
| gptkbp:heldBy |
A patent licensee does not have to breach its license agreement before seeking a declaratory judgment that the underlying patent is invalid, unenforceable, or not infringed.
|
| https://www.w3.org/2000/01/rdf-schema#label |
MedImmune (2007)
|
| gptkbp:legalIssue |
patent licensee standing to challenge validity of a patent while continuing to pay royalties
|
| gptkbp:majorityOpinionBy |
gptkb:Justice_Antonin_Scalia
|
| gptkbp:officialName |
MedImmune, Inc. v. Genentech, Inc.
|
| gptkbp:petitioner |
MedImmune, Inc.
|
| gptkbp:predecessor |
patent litigation
|
| gptkbp:response |
Genentech, Inc.
|
| gptkbp:bfsParent |
gptkb:AstraZeneca_plc
|
| gptkbp:bfsLayer |
7
|